Suppr超能文献

玫瑰糠疹患者血清白细胞介素-36:疾病严重程度的潜在生物标志物

Serum Interleukin-36 in Pityriasis Rosea: A Potential Biomarker for Disease Severity.

作者信息

Sanad Eman M, Ibrahim Mays, Rachwan Maha, Shams Ghada M

机构信息

Dr. Sanad and Dr. Shams are with the Department of Dermatology, Venereology and Andrology, and Faculty of Medicine at Benha University, in Banha, Egypt.

Mr. Ibrahim is with the Faculty of Medicine at Benha University in Banha, Egypt.

出版信息

J Clin Aesthet Dermatol. 2023 May;16(5):43-46.

Abstract

OBJECTIVE

Pityriasis rosea (PR) is a self-limiting acute rash with unclear etiology and pathogenesis. The cytokine profile of PR is an infrequently investigated field of research. The aim of this study was to assess the level of IL-36 in sera of patients with PR and its possible interrelation with disease severity.

METHODS

Forty patients with PR were included in this case-control study, and 40 comparable healthy control subjects. Severity was assessed using pityriasis rosea severity score (PRSS) and serum IL-36 was assessed using ELISA.

RESULTS

Serum IL-36 was significantly higher in patients (30.36±12.35) pg/mL compared to control subjects (18.76±10.24) pg/mL (P=0.003). It correlates positively with severity as assessed by PRSS (= 627, = 0.003). Patients who reported a history of COVID-19 had significantly higher levels of IL-36 (32.66±11.79) pg/mL compared to those who have not (17.33±2.08) pg/mL (= 0.000).

CONCLUSION

Serum IL-36 could be considered a potential biomarker for pityriasis rosea that correlates with the disease severity.

摘要

目的

玫瑰糠疹(PR)是一种病因和发病机制不明的自限性急性皮疹。玫瑰糠疹的细胞因子谱是一个较少被研究的领域。本研究的目的是评估玫瑰糠疹患者血清中白细胞介素-36(IL-36)水平及其与疾病严重程度的可能相关性。

方法

本病例对照研究纳入了40例玫瑰糠疹患者和40例匹配的健康对照者。使用玫瑰糠疹严重程度评分(PRSS)评估疾病严重程度,采用酶联免疫吸附测定(ELISA)法检测血清IL-36水平。

结果

患者血清IL-36水平(30.36±12.35)pg/mL显著高于对照者(18.76±10.24)pg/mL(P = 0.003)。血清IL-36水平与PRSS评估的疾病严重程度呈正相关(r = 0.627,P = 0.003)。有新型冠状病毒肺炎(COVID-19)病史的患者血清IL-36水平(32.66±11.79)pg/mL显著高于无该病史者(17.33±2.08)pg/mL(P =  0.000)。

结论

血清IL-36可被视为玫瑰糠疹的潜在生物标志物,且与疾病严重程度相关。

相似文献

2
The role of interleukin-22 in pityriasis rosea.白细胞介素-22在玫瑰糠疹中的作用。
Clin Exp Dermatol. 2017 Jan;42(1):30-35. doi: 10.1111/ced.12976. Epub 2016 Nov 11.
5
Narrowband UVB phototherapy in pityriasis rosea.玫瑰糠疹的窄谱中波紫外线光疗
Indian Dermatol Online J. 2015 Sep-Oct;6(5):326-9. doi: 10.4103/2229-5178.164480.
6
Low-dose Ultraviolet A1 Phototherapy for Treating Pityriasis Rosea.低剂量紫外线A1光疗治疗玫瑰糠疹
Ann Dermatol. 2009 Aug;21(3):230-6. doi: 10.5021/ad.2009.21.3.230. Epub 2009 Aug 31.
7
Interventions for pityriasis rosea.玫瑰糠疹的干预措施。
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD005068. doi: 10.1002/14651858.CD005068.pub3.

本文引用的文献

1
Pityriasis Rosea Induced by COVID-19 Vaccination.新冠疫苗接种诱发的玫瑰糠疹
Eur J Case Rep Intern Med. 2022 Feb 3;9(2):003164. doi: 10.12890/2022_003164. eCollection 2022.
3
Pityriasis rosea-like eruption revealing COVID-19.玫瑰糠疹样皮疹揭示新型冠状病毒肺炎
Australas J Dermatol. 2021 May;62(2):e333-e334. doi: 10.1111/ajd.13504. Epub 2020 Nov 20.
6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验